Wall Street brokerages expect Innophos Holdings, Inc. (NASDAQ:IPHS) to post $0.76 earnings per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Innophos Holdings’ earnings. Innophos Holdings reported earnings per share of $0.75 in the same quarter last year, which suggests a positive year over year growth rate of 1.3%. The company is expected to announce its next earnings report on Thursday, October 26th.
On average, analysts expect that Innophos Holdings will report full year earnings of $2.50 per share for the current financial year. For the next financial year, analysts expect that the company will post earnings of $2.65 per share. Zacks’ earnings per share calculations are an average based on a survey of analysts that cover Innophos Holdings.
Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.05. Innophos Holdings had a net margin of 6.46% and a return on equity of 13.79%. The firm had revenue of $179.14 million during the quarter, compared to the consensus estimate of $172.65 million. During the same period last year, the firm posted $0.63 EPS. The firm’s quarterly revenue was down 1.5% on a year-over-year basis.
A number of brokerages have issued reports on IPHS. Zacks Investment Research upgraded shares of Innophos Holdings from a “hold” rating to a “strong-buy” rating and set a $54.00 price objective on the stock in a research note on Tuesday, August 8th. BidaskClub downgraded shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Finally, Sidoti upgraded shares of Innophos Holdings from a “neutral” rating to a “buy” rating in a research note on Friday, May 26th. They noted that the move was a valuation call.
ILLEGAL ACTIVITY WARNING: This news story was posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/1487764-2/1487764.html.
A number of large investors have recently made changes to their positions in IPHS. Goldman Sachs Group Inc. increased its stake in shares of Innophos Holdings by 58.1% in the second quarter. Goldman Sachs Group Inc. now owns 321,140 shares of the specialty chemicals company’s stock worth $14,079,000 after buying an additional 118,043 shares during the last quarter. QS Investors LLC increased its stake in shares of Innophos Holdings by 4.1% in the second quarter. QS Investors LLC now owns 51,625 shares of the specialty chemicals company’s stock worth $2,263,000 after buying an additional 2,032 shares during the last quarter. Voya Investment Management LLC increased its stake in shares of Innophos Holdings by 8.2% in the second quarter. Voya Investment Management LLC now owns 10,214 shares of the specialty chemicals company’s stock worth $448,000 after buying an additional 776 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Innophos Holdings by 0.4% in the second quarter. Dimensional Fund Advisors LP now owns 973,461 shares of the specialty chemicals company’s stock worth $42,676,000 after buying an additional 3,717 shares during the last quarter. Finally, Renaissance Technologies LLC increased its stake in shares of Innophos Holdings by 1.5% in the second quarter. Renaissance Technologies LLC now owns 770,700 shares of the specialty chemicals company’s stock worth $33,787,000 after buying an additional 11,679 shares during the last quarter. Hedge funds and other institutional investors own 94.76% of the company’s stock.
Shares of Innophos Holdings (IPHS) traded up 0.69% during trading on Monday, reaching $45.30. 64,625 shares of the company traded hands. Innophos Holdings has a 12 month low of $37.02 and a 12 month high of $58.22. The stock has a market capitalization of $878.64 million, a PE ratio of 19.78 and a beta of 0.85. The company has a 50-day moving average of $44.11 and a 200-day moving average of $47.08.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 6th. Shareholders of record on Friday, August 18th will be paid a dividend of $0.48 per share. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.92 dividend on an annualized basis and a yield of 4.24%. Innophos Holdings’s payout ratio is 84.21%.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.